Please login to the form below

Not currently logged in
Email:
Password:

GK Strategy appoints head of health and social care

Andrew Nye joins the public affairs consultancy

GK Strategy Andrew NyePublic affairs consultancy GK Strategy has appointed Andrew Nye to the newly-created position of head of health and social care.

Nye will be responsible for overseeing GK's health practice and developing the team's strategic counsel offering for pharmaceutical clients navigating market access.

He brings 20 years of public affairs and communications expertise to the role, joining from Novartis where he spent the last five years as its senior corporate affairs manager.

Nye has also worked for local and central government as well as charities, serving as head of communications at Islington Council and chair of mental health charity Umbrella.

Emily Wallace, chief executive of GK Strategy, said: “Andrew joins GK at an exciting time for the business which has doubled in size over the last two years.

“He will head up a new health and social care practice at GK, servicing a varied client base generating nearly £1m of revenue.”

9th November 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics